| ||
| Gold Extends Sell Off As Year End Beckons Traders India Infoline.com Asian markets witnessed a subdued start today with the commodity prices dropping slightly while equities were also pressed lower. COMEX Gold futures broke ... See all stories on this topic » |
| ||
| MARKET COMMENT: Europe Stocks Fall, Breaking Winning Streak Wall Street Journal By Simon Kennedy LONDON (Dow Jones)---Spain led a broad decline for European markets after Moody's Investors Service warned Wednesday it may downgrade the ... See all stories on this topic » | ||
| Stocks Drift Lower as Dollar Climbed (AA, APC, BAC, BP, CAT, JOYG, JPM, RIG) TradersHuddle.com The Dow Jones Industrial Average fell 19.07 points, or 0.17%. The S&P 500 index lost 6.36 points, or 0.51%, while the NASDAQ fell 10.50 points, or 0.40%. ... See all stories on this topic » |
| ||
|
| ||
| Oil Prices Continue Slide despite Canadian Pipeline Restart Forexyard ... in trading yesterday, suggesting the slide in oil prices were being driven by USD factors. Today's economic figures will likely have similar results. ... See all stories on this topic » | ||
| Gold and Silver Drop as Dollar Rebounds Forexyard Crude oil prices were resistant to the commodity selling as better than expected inventory numbers helped support prices. The US dollar regained its footing ... See all stories on this topic » |
| ||
| Comex Gold ends down as US Dollar Index gains Commodity Online By Jim Wyckoff of Kitco News (Kitco News) - Comex gold futures prices ended lower and near the daily low Wednesday. The market was pressured by a stronger ... See all stories on this topic » | ||
| Forecasts for gold, silver, copper for 2011 Commodity Online By Alex Létourneau Montréal (Kitco News): Average gold and silver prices will rise in 2011 as investors continue to turn to precious metals as a hedge, ... See all stories on this topic » |
| ||
| Gold May Decline as US Data, European Debt Concern Aid Dollar BusinessWeek "We would expect to see some weakness in gold prices in the next few days." The greenback was little changed against a basket of six other currencies today ... See all stories on this topic » |
| ||
| Sinking Euro Puts Lid on Stocks Fox Business ... stocks landed in the red on Wednesday, backing the Dow away from levels unseen since September 2008. The Dow Jones Industrial Average fell 19.07 points, ... See all stories on this topic » |
| ||
| KKR Invests In China's VATS Liquor Store Wall Street Journal SHANGHAI (Dow Jones)--KKR & Co. (KKR) has invested in Chinese liquor store chain operator VATS Liquor Store to tap China's fast growing liquor distribution ... See all stories on this topic » | ||
| Big Yuan FX Rate Move Would Hurt China's Economic Stability - PBOC-Backed Paper Wall Street Journal BEIJING (Dow Jones)--A big movement in the yuan exchange rate would have a large impact on China's economic and financial stability next year, ... See all stories on this topic » | ||
| Nomura Sees Euro Down To $1.30 By End 2010 On Spain Concerns Wall Street Journal NEW YORK (Dow Jones)--The euro will fall to $1.30 by the end of this year on concerns about European sovereign debt centered on Italy and especially Spain, ... See all stories on this topic » | ||
| S Korea's Woori Finance Stake Sale Plan Under Review Wall Street Journal By Se Young Lee SEOUL (Dow Jones)--South Korean officials are reviewing plans for the sale of a majority stake in Woori Finance Holdings Co. (053000. ... See all stories on this topic » |
| ||
| Clearwater Seafoods signs deal regarding is Icelandic-krona denominated debt CanadianBusiness.com By The Canadian Press HALIFAX - Clearwater Seafoods LP (TSX:CLR.UN) said Wednesday it has signed a deal to extend and partially settle its Icelandic-krona ... See all stories on this topic » |
| ||
| Healthcare Stocks Focus Report on: CYBX, MDT, EW Chart Poppers Healthcare stocks are on the rise today despite both the Dow Jones and the S&P 500 closing down slightly on the day. Today we take a look at 3 different ... See all stories on this topic » |
| ||
| Most actively traded companies on the TSX, TSX Venture Exchange markets CanadianBusiness.com (blog) (TSX:BIM). Mining. Up 11 cents, or 9.73 per cent, at $1.24 on 25967716 shares. The private equity firm that has made a hostile takeover bid for Baffinland ... See all stories on this topic » | ||
| Northquest Ltd. Announces Private Placement Financing DigitalJournal.com (press release) The private placement remains subject to the approval of the TSX Venture Exchange. Forward Looking Statements - Certain information set forth in this news ... See all stories on this topic » | ||
| George Weston to pay one-time dividend totalling $1 billion to shareholders CanadianBusiness.com (blog) By The Canadian Press TORONTO - George Weston Ltd. (TSX:WN) said Wednesday it will pay a special one-time dividend totalling $1 billion to its shareholders. ... See all stories on this topic » | ||
| High Liner gets OK to buy back up to 5 per cent of common, non-voting shares CanadianBusiness.com By The Canadian Press LUNENBURG, NS - High Liner Foods Inc. (TSX:HLF) said Wednesday that it has received TSX approval for a share buyback of up to five per ... See all stories on this topic » |
| ||
| ||
| Insight from a Master Gold Prices And if they're good companies, they should outperform the gold price because they're generating a lot of earnings and cash flow at these prices. ... See all stories on this topic » |
| ||
| Peru's Main Stock Indexes End Lower; Sol Unchanged Wall Street Journal LIMA (Dow Jones)--Peru's stock market ended lower Wednesday, dragged down by weakness in the mining sector. The Lima Stock Exchange's broad General index ... See all stories on this topic » |
| ||
| TODAY'S STOCK MARKET DOW JONES INDUSTRIAL AVERAGE DJI, S&P 500, NASDAQ INDEX ... Learning and Finance The Nasdaq and Dow Jones Industrial Average however were just into the green at the half way point. Index values were higher earlier in the day today but ... See all stories on this topic » | ||
| TIC: Foreigners Net Buyers Of US Assets In Oct Wall Street Journal By Ian Talley and Meena Thiruvengadam Of DOW JONES NEWSWIRES WASHINGTON (Dow Jones)--China bought US Treasurys in October, boosting its holdings to the ... See all stories on this topic » | ||
| Dow Jones: Regions Financial Corp. not in talks with PNC The Birmingham News - al.com (blog) based BankAtlantic Bancorp. Sources told Dow Jones that PNC isn't in discussions to buy Regions. PNC and Regions declined to comment on the report. See all stories on this topic » |
| ||
| Ben Potter, Research Analyst, IG Markets IG Markets CFD Trading The broad-based S&P 500 was the worst performer, down 0.5%, while the NASDAQ fell 0.4% and the Dow Jones industrial Average 0.2%. ... See all stories on this topic » |
| ||
| Clearwater Seafoods signs deal regarding is Icelandic-krona denominated debt Winnipeg Free Press HALIFAX - Clearwater Seafoods Limited Partnership (TSX:CLR.UN) said Wednesday it has signed a deal to extend and partially settle its Icelandic-krona ... See all stories on this topic » |
dow2664
Negocioenlinea
Stocks moved ahead yesterday during the U.S. trading session but fell off a bit towards end of day close. Positive economic reports bolstered index values throughout the day however and the Dow, Nasdaq and S&P 500 trending stayed green. The Dow moved ahead almost 50 points altogether. The Fed reported that the economic recovery was still in need of Federal intervention and their plan of QE2 would be implemented without major revision. Current index values prior to opening bell for the U.S. trading session today reveal that trending is in the red. The Dow Jones Industrials are down by .42%. The Nasdaq is down by .50% and the S&P 500 is lower by .49%. Major Asian and European index values are trending red right now as well. The Nikkei 225 and Hang Seng are trending red as are the FTSE 100 and the DAX. For today’s U.S. session, the U.S. consumer price index will post prior to opening session as will the empire manufacturing survey and government data on industrial production. Tomorrow will bring the government's weekly report on initial claims for jobless benefits which is expected to rise slightly from numbers observed last week. A housing starts report will post this day as well. It is a busy week in the market. Author: Frank Matto
gol2664
Negocioenlinea
Fingernail-Biting Time for Randgold Resources Africa Intelligence – Dec 14, 2010 Accustomed to working in risky environments, Randgold Resources is monitoring the situation from hour to hour after the Nov. 28 runoff in the presidential elections led to both contenders claiming …
dow2664
Negocioenlinea
Ken Fisher is a money manager, and on the list of the Forbes 400 Richest Americans. He is also a Forbes columnist, where he recently recommended several income stocks, such as Sims Metal Management (SMS), Net Servicos de Comunicacao (NETC), and PetroChina (PTR). His latest book, Debunkery: Learn It, Do It, and Profit from It-Seeing Through Wall Street’s Money-Killing Myths was just published. He is also author of several other books, including The Ten Roads to Riches: The Ways the Wealthy Got There (And How You Can Too!) and How to Smell a Rat: The Five Signs of Financial Fraud Ken Fisher Interview Part 7 Please note: The complete interview took place on Wednesday, October 27, 2010 Stockerblog: There was an article recently about how some investors got early retirement, they had nothing better to do, did a lot of research on their stocks, and were very successful. The article talked about one guy who built his portfolio from $30,000 to $3,000,000. Do you think that article was about an aberration or just looking at one end of the bell curve? Fisher: That’s looking at the very few people who are definitely one tip of the bell curve. And it’s not the average investor that could possibly consider it unless they had an extreme amount of luck to achieve anywhere near that. The average investor by definition cannot do that. The average investor cannot possibly beat the market. The average investor, at most, can equal the market. Stockerblog: Speaking of playing the market, the Bunk chapter on swine flu and some of the other things. It seems like someone who trades or does short term investing could actually play the opposite of some of these bunks. The swine flu could be an example or some other major catastrophe where the market has a temporary sell-off, and if you are mentally set to go into the market to do the opposite, a trader could actually do fairly well playing to opposite of the common bunks. Would you agree with that? Fisher: I think that’s possible but for the average person that thinks it's a trade, that he or she is a trader, is exceptionally unlikely. In fact, when we look at the history of traders, most of them don’t do very well. Said another way, if you say who are the traders we can think of that have become legendary investors, are really, really rich and successful as traders, there aren’t very many of them; although we have a lot of traders in total, which tells you that it’s another one of those things where it's a tip of the bell curve where people have a knack to do that but they’re very unusual and they are probably least like our primitive stone age ancestors. They probably have the leave behavioral finance issues embedded into their brains for some reason. But there aren’t very many of those people and the odds of anyone being one of those people is small. If the person that can trade these things, which I do believe there are people who can do it but its not me that’s for sure, if there are people good enough to trade these, they are good enough to trade all kinds of other things. So another one of the bunks that you will remember reading about is my comments about gold, and gold is basically a thing where if you’re a very good trader, gold might be a good thing for you but gold has had an OK return but a huge volatility over time, and 85% of history on a monthly basis has lost money, and made all its total return out of 15% of the months. If you’re a good enough trader, you should be able to trade gold successfully and you should be able to trade all kins of other things too. And you don’t need an trading advice from me, that’s for darn sure. The fundamental nature of those rare George Soros like traders or Paul Tudor Jones type people, the people at have made money off of trading that have gotten good returns and have had some consistency, because you can trade gold, you can trade oil, you can probably trade swine flu, but most people aren’t very good traders. End of Part 7 The Debunkery book is available at Amazon . Ken Fisher obviously doesn’t give individual stock recommendations in his interviews, but some stocks he likes that were mentioned in his recent Forbes columns, including high dividend stocks, are available in the form of a free Excel list at WallStreetNewsNetwork.com. Part 1 of this interview is available HERE . Part 2 of this interview is available HERE . Part 3 of this interview is available HERE . Part 4 of this interview is available HERE . Part 5 of this interview is available HERE . Part 6 of this interview is available HERE . By Fred Fuld at Stockerblog.com Disclosure: Interviewer doesn’t own any of the stocks mentioned in this interview series at the time the articles were written. Copyright 2010. All rights reserved. Reproduction of this interview prohibited without permission. All opinions are those of Ken Fisher, and do not represent the opinions of Stockerblog.com or the interviewer. Neither Stockerblog nor the interviewer nor the interviewee are rendering tax, legal, or investment advice in this interview. If you want tax, legal, or investment advice, contact the appropriate professional.
Exclusive Interview with Ken Fisher Part 7 – Can Traders Make Money
dow2664
Negocioenlinea
FTSE 100 down 0.25%, Dow Jones and S&P 500 futures decline Proactive Investors UK – 2 hours ago The FTSE 100 declined 0.25% in morning trade, dragged down by rising concerns over Spain's debt woes. It was reported this morning that UK claimant count rate remained at 4.5% in November, while …
FTSE 100 down 0.25%, Dow Jones and S&P 500 futures decline
UnitedHealth Group Inc. (NYSE:UNH) fell 1.03% to $36.46. UnitedHealth Group Incorporated (UnitedHealth Group) is a diversified health and well-being company. The Company operates in four business segments: Health Benefits, which includes UnitedHealthcare, Ovations and AmeriChoice; OptumHealth; Ingenix and Prescription Solutions. The stock has average daily volume of 8.37 million shares. At current market price, the market capitalization of the company stands at $40.10 billion. Geron Corporation (NASDAQ:GERN) lost 1.44% to $4.79. Geron Corporation (Geron) is a biopharmaceutical company that is developing biopharmaceuticals for the treatment of cancer and chronic degenerative diseases, including spinal cord injury, heart failure and diabetes. The Company is advancing telomerase targeted therapies, including an anti-cancer drug and a cancer vaccine, through multiple clinical trials. Amgen, Inc. (NASDAQ:AMGN) is up 0.33% to $53.46. The 52-week range of the stock is $50.26-$61.26. The stock is down more than 5% year-to-date. Amgen Inc. (Amgen) is an independent biotechnology medicines company. The Company discovers, develops, manufactures and markets medicines for grievous illnesses. It focuses on human therapeutics and concentrates on medicines based on advances in cellular and molecular biology.
tdp2664
Newsworthy Stocks
Activision Blizzard (NASDAQ: ATVI ) is continuing its strong finish to 2010 — a welcome relief to investors. The video game maker said Monday that Cataclysm, the latest edition of its computer-based megahit World of Warcraft series, sold 3.3 million copies in its first 24 hours of release last week. That beat the first-day sales by the games predecessor, Wrath of the Lich King , which sold 2.8 million copies in the first 24 hours of its release two years ago. But Cataclysm also is the second first-day multimillion-seller for Activision in less than a month. The first, the company’s Call of Duty: Black Ops game, sold 5.6 million copies on its first day of release on Nov. 9. One could forgive ATVI shareholders for being anxious for the second half of 2010, as shares had shown an inability to move higher — and stay there — since the stock market’s post-financial crisis run-up in early 2009. Before the release of Black Ops in November , ATVI was trading at around $11 — almost exactly where it was this time last year. The company recovered during its third quarter, thanks in large part to PC game Starcraft II: Wings of Liberty released for Microsoft (NASDAQ: MSFT ) Windows PCs and Apple Inc. (NASDAQ: AAPL ) Mac computers in July, selling 1 million copies in its first 24 hours and 3 million games during its first month. The company’s unexpected success in that quarter, however, was a surge in World of Warcraft sales that brought the game’s worldwide subscriber base up to 12 million. Whilethe surge was in part fueled by Wrath of the Lich King’s release in China, it was still unexpected growth preceding last week’s release of Cataclysm worldwide. Released at the end of 2004, World of Warcraft has remained the tent pole of Activision’s video game business. While the company has had several industry-defining successes over the past half decade — the Call of Duty franchise earned more than $3 billion between 2003 and 2009 — none have been as enduring as Warcraft . And no other game continues to provide as much revenue after the initial point of sale. Unlike ATVI’s billion-dollar Guitar Hero franchise, Warcraft’s market can never become saturated since the game itself is an ever-evolving commodity. It’s what is known as a massively multiplayer role-playing game, a persistent game played simultaneously by consumers all over the world who pay $14.99 a month to play. (Subscription plans vary outside the U.S.) While the base game has been in place since 2004, it has been augmented with secondary releases, or “expansions,” that redefine the game’s features and introduces new content. Even though ATVI shares are currently trading at about $12, and have climbed about 7% since the release of Call of Duty: Black Ops – near their 52-week high of $12.58 — the stock still could be a smart buy. Shareholders who held on through a tumultuous 2010 are already recovering, and new investors could see significant returns based on the fourth-quarter success of both Cataclysm and Black Ops . It’s likely that Cataclysm has performed even better than reported — the 3.3 million-game sales figure is based on retail sales only, not digital downloads. Considering that BattleNet, the company’s online home for Warcraft products online,is one of the top five digital storefronts for PC and Mac games, it’s reasonable to assume that a sizable chunk of release revenue is absent from this announcement. Still, new buyers should keep a close eye on the company’s activity early next year. While a new Starcraft II release is planned for next year as well as a new sequel to its Diablo game series, it’s not yet clear when they’ll be unveiled. ATVI should remain healthy into 2011, but traders may want to consider lightening up on the stock if schedule delays begin to pop up. As of this writing, Anthony Agnello did not own a position in any of the stocks named here.
tdp2664
gol2664
InvestorPlace
Capstone Therapeutics Corp (NASDAQ:CAPS) plunged 52.38% to trade at $0.495 after the Company announced an unfavorable twelve-month results from its two AZX100 Phase 2a pilot clinical trials in keloid scarring. Shares of the Company fell 53 cents and hit its new 52-week low of $0.45 on the opening of the market. 2.59 million shares of the Company exchanged hands as compared to the 3 month average trading volume of 0.177 million shares. The Company has a market capitalization of $20.72 million on 40.78 million shares as on the current market prices. The Company had however shown a favorable safety profile from its seven-month interim analysis of the Phase 2a pilot surgical (trocar site) scarring trial, and revealed multiple signals of AZX100 efficacy. The occurrence of the favorable results was more frequent within the 3.0 mg trocar sites than within sites receiving 10.0 mg. Additional statistical data is yet to be determined as the study is still ongoing. Two tests had been conducted by the biotechnology company for the reduction or prevention of post-excision keloid scarring. The two pilot Phase 2a clinical trials of AZX100 included OL-ASCAR-04, with dosing at 3.0 mg or 10.0 mg per linear cm; and OL-ASCAR-05, with dosing at 0.3 mg or 1.0 mg per linear cm. In these trials, AZX100 (or placebo) was administered 21 and 42 days following surgery, with no additional dosing throughout the remainder of the trial. Fifty-nine subjects were dosed in each of these two pilot keloid scarring trials. The twelve-month AZX100 Phase 2a pilot clinical trials did not meet the study objective of demonstrating statistically-significant efficacy based on differences in this scale between AZX100 and placebo at the single Month 12 time point, though the trial showed a favorable safety profile for AZX100. Secondary endpoints showed multiple signals of AZX100 efficacy within the1.0 mg-per-linear-cm cohort, particularly at earlier time points but no significant benefit was observed for the other AZX100 doses. The endpoints of the trials included blinded, independently-scored Visual Analog Scales (VAS) and objective measurements of scar dimensions. Each of the endpoints of these trials was being evaluated for its potential to guide and inform future studies of AZX100 in dermal indications. Keloid scars are among the most difficult dermatologic conditions to treat, and there are no currently-approved therapeutic agents specifically indicated for these scars. The Company believes that the clinical data of AZX100 merited its continued development and the Company on the basis of its trial's results seeks a collaboration partner to advance AZX100 in both surgical and keloid scar reduction. Capstone Therapeutics is a biotechnology company committed to developing a pipeline of novel therapeutic peptides aimed at helping patients with under-served medical conditions. The Company is focused on development and commercialization of two product platforms: AZX100 and Chrysalin (rusalatide acetate or TP508). Disclaimer: The assembled information distributed by epicstockpicks.com is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Epicstockpicks.com does expect that investors will buy and sell securities based on information assembled and presented herein. EpicStockPicks.com will not be responsible in any way for or accept any liability for any losses arising from an investor's reliance on or use of information obtained from our website or emails. PLEASE always do your own due diligence, and consult your financial advisor.
tdp2664
Epic Stock Picks
Below are today's Analyst Actions on U.S.-Listed Chinese Stocks.
Raymond James maintained Market Perform rating on CDC Corporation (NASDAQ:CHINA). Nomura maintained Buy rating and HK$95 price target on the Hong Kong-listed shares of China Mobile Ltd. (NYSE:CHL). Auriga USA maintained Buy rating and $30 price target on Focus Media Holding Limited (NASDAQ:FMCN). Jefferies & Company initiated coverage of Funtalk China Holdings Ltd. (NASDAQ:FTLK) with Hold rating and $7 price target. Deutsche Bank maintained Buy rating and $57 price target on Home Inns & Hotels Management Inc. (NASDAQ:HMIN). Roth Capital Partners maintained Buy rating and $60 price target on Home Inns & Hotels Management Inc. (NASDAQ:HMIN). Morgan Joseph maintained Hold rating on Zhongpin, Inc. (NASDAQ:HOGS). Deutsche Bank reiterated Buy rating on Mindray Medical International Limited (NYSE:MR), with $32 price target. Yesterday Roth Capital Partners upgraded ShengdaTech, Inc. (NASDAQ:SDTH) from Neutral to Buy, and cut price target from $6.50 to $6.00. Chardan Capital Markets reiterated Buy rating on Spreadtrum Communications, Inc. (NASDAQ:SPRD), and raised price target from $20 to $23.
tdp2664
China Analyst
Analyst Actions on Chinese Stocks: CHINA, CHL, FMCN, FTLK, HMIN, HOGS, MR, SDTH … (Dec 14, 2010)
dow2664
Cash is king. If you don’t believe it, look at Apple (AAPL), with more than $25 billion in cash. On top of that, the company is debt free. Maybe that is why the stock is up over 345% over the last five years. Many investors look for debt free stocks selling at or near cash per share. These are stocks which have virtually no debt and are trading close to the amount of cash the company has on a per share basis. Without any debt and a lot of cash, it would be hard for a company to go out of business, unless it is a biotech company with a high burn rate. In addition, the cash might make the company a possible takeover candidate. WallStreetNewsNetwork.com just updated its list of Low Price to Cash per Share Ratio Stocks with No Debt , which shows the recent price, cash per share, forward PE, and price per cash ratio. Almost all the stocks have price to cash ratios less than 4. On example is Electronic Arts Inc. (ERTS), the video game manufacturer, has $4.99 in cash per share, with the stock selling at less than 15.80, giving it a 3.16 price to cash ratio. The company, with no debt, has a forward PE of 18.8. FormFactor Inc. (FORM) is another stock with lots of cash. This debt-free manufacturer of semiconductor wafer probe card products, which sells for less than 9.50 per share, has a significant $7.35 per share in cash. Recent earnings were negative, however, revenues for the latest quarter were up 8.2%. If you want a free downloadable Excel list of ten stocks that have a Low Price to Cash Ratio with No Debt , go to wsnn.com. Disclosure: Author did not own any of the above stocks at the time the article was written. By Stockerblog.com
Stocks with Lots of Cash and No Debt
dow2664
Comtex SmarTrend(R) Morning Call — December 15, 2010 Benzinga – 24 minutes ago A tepid economic growth outlook from the Fed catalyzed a late session sell off by the market indices, which neutralized some, but not all, earlier day stock gains. The DJIA closed up 48 points at …
Comtex SmarTrend(R) Morning Call — December 15, 2010
International Coal Group Inc. ( NYSE: ICO ) is engaged in the production of coal in Northern and Central Appalachia with a variety of mid to high British thermal unit, low to medium sulfur system and metallurgical coal. International Coal Group today announced the pricing of its common stock offering. The company also said that the underwriter to the offering will have an option to buy up to an additional 1,840,305 and 3,386,670 shares of common stock from affiliates of WL Ross & Co. and Fairfax Financial Holdings Limited. The International Coal Group stock has a 52-week range of $3.36-$8.59. Year-to-date, the stock is up 84.33%. Patriot Coal Corporation ( NYSE: PCX ) is a St. Louis, Missouri-based producer of coal in the eastern United States, with operations and coal reserves in Appalachia and the Illinois Basin. Patriot Coal announced its third-quarter financial results in October. The company reported third-quarter EBITDA of $13.2 million. The company's third-quarter revenue came in at $500.7 million. It reported a net loss of $46 million for the third quarter of 2010. The Patriot Coal stock has a 52-week range of $9.76-$24.25. Year-to-date, the stock is up 8.99%. Arch Coal Inc. ( NYSE: ACI ) is a St. Louis Missouri-based coal producer. In 2009, the company sold around 126.1 million tons of coal. Arch Coal reported its third-quarter financial results in October. The company reported a 67% increase in its third-quarter EBITDA of $201 million. The company's cash flow grew 85% on a year-over-year basis. It reported revenue of $874.7 million. The Arch Coal stock has a 52-week range of $19.09-$34.18. Year-to-date, the stock is up 45.08%. CONSOL Energy Inc. ( NYSE: CNX ) is a Canonsburg, Pennsylvania-based multi-fuel energy producer and energy services provider. The company primarily serves the electric power generation industry in the U.S. CONSOL Energy reported its third-quarter financial results in October. The company reported record revenue of $1.319 billion for the third quarter of 2010. The CONSOL Energy stock has a 52-week range of $31.08-$58. Year-to-date, the stock is down 13.86%. James River Coal Company ( NASDAQ: JRCC ) is a Richmond, Virginia-based company, engaged in mining, processing and sales of bituminous, steam and industrial grade coal. The James River Coal stock has a 52-week range of $14.44-$23.99. Year-to-date, the stock is up 23.74%. This corporate profile is provided for information purposes only and should not be used as the basis for any investment decision. We are neither licensed nor qualified to provide investment advice. We were not paid, nor do we hold a position in these stocks. We reserve the right to buy or sell ICO, PCX, ACI, CNX and JRCC at any time after this post.
tdp2664Penny Stock Live
